Cargando…

Drug Therapy Trials for the Prevention of Bronchopulmonary Dysplasia: Current and Future Targets

Detalles Bibliográficos
Autor principal:	Bhandari, Vineet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110623/ https://www.ncbi.nlm.nih.gov/pubmed/25121076 http://dx.doi.org/10.3389/fped.2014.00076

Ejemplares similares

Respiratory support strategies in the prevention and treatment of bronchopulmonary dysplasia
por: Hysinger, Erik B., et al.
Publicado: (2023)

Perspectives on Probiotics and Bronchopulmonary Dysplasia
por: Yang, Kun, et al.
Publicado: (2020)

Molecular Mechanism of Caffeine in Preventing Bronchopulmonary Dysplasia in Premature Infants
por: Tian, Congliang, et al.
Publicado: (2022)

Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant
por: Rivera, Lidys, et al.
Publicado: (2016)

Pharmacotherapy in Bronchopulmonary Dysplasia: What Is the Evidence?
por: Sakaria, Rishika P., et al.
Publicado: (2022)

Editorial: Bronchopulmonary dysplasia: latest advances
por: Perveen, Shahana, et al.
Publicado: (2023)

Pulmonary Biomarkers of Bronchopulmonary Dysplasia
por: Thompson, Alecia, et al.
Publicado: (2008)

An Innovative Model of Bronchopulmonary Dysplasia in Premature Infants
por: Zhang, Xiaoyue, et al.
Publicado: (2020)

T Lymphocytes, Multi-Omic Interactions and Bronchopulmonary Dysplasia
por: Toldi, Gergely, et al.
Publicado: (2021)

Patho-mechanisms of the origins of bronchopulmonary dysplasia
por: Sahni, Mitali, et al.
Publicado: (2021)

NOVEL BIOMARKERS OF BRONCHOPULMONARY DYSPLASIA AND BRONCHOPULMONARY DYSPLASIA-ASSOCIATED PULMONARY HYPERTENSION
por: Sahni, Mitali, et al.
Publicado: (2020)

Drug therapy for the prevention and treatment of bronchopulmonary dysplasia
por: Iyengar, Anjali, et al.
Publicado: (2015)

Risk Factors for Tracheobronchomalacia in Preterm Infants With Bronchopulmonary Dysplasia
por: Su, Ya-Ting, et al.
Publicado: (2021)

Respiratory Tract Microecology and Bronchopulmonary Dysplasia in Preterm Infants
por: Sun, Tong, et al.
Publicado: (2021)

Tracheostomy in infants with severe bronchopulmonary dysplasia: A review
por: Akangire, Gangaram, et al.
Publicado: (2023)

Recent advances in understanding and management of bronchopulmonary dysplasia
por: Sahni, Mitali, et al.
Publicado: (2020)

Can biomarkers be used to predict bronchopulmonary dysplasia?()
por: Bhandari, Vineet, et al.
Publicado: (2020)

Respiratory support strategies in the prevention of bronchopulmonary dysplasia: A single center quality improvement initiative
por: White, Heather, et al.
Publicado: (2022)

Novel Strategies to Reduce Pulmonary Hypertension in Infants With Bronchopulmonary Dysplasia
por: El-Saie, Ahmed, et al.
Publicado: (2020)

High Neutrophil-to-Lymphocyte Ratio Is an Early Predictor of Bronchopulmonary Dysplasia
por: Sun, Yuanyuan, et al.
Publicado: (2019)

The Correlation Between Bronchopulmonary Dysplasia and Platelet Metabolism in Preterm Infants
por: Yan, Longli, et al.
Publicado: (2021)

Respiratory support strategies in the management of severe, longstanding bronchopulmonary dysplasia
por: Logan, J. Wells, et al.
Publicado: (2022)

Risk prediction of bronchopulmonary dysplasia in preterm infants by the nomogram model
por: Gao, Yang, et al.
Publicado: (2023)

Genomics, microbiomics, proteomics, and metabolomics in bronchopulmonary dysplasia
por: Lal, Charitharth Vivek, et al.
Publicado: (2018)

Vitamin D and IL-10 Deficiency in Preterm Neonates With Bronchopulmonary Dysplasia
por: Mao, Xiaonan, et al.
Publicado: (2018)

Bronchopulmonary Dysplasia: Comparison Between the Two Most Used Diagnostic Criteria
por: Gomez Pomar, Enrique, et al.
Publicado: (2018)

Oxidative Stress and Bronchopulmonary Dysplasia: Evidences From Microbiomics, Metabolomics, and Proteomics
por: Capasso, Letizia, et al.
Publicado: (2019)

Prediction of Bronchopulmonary Dysplasia in Preterm Infants Using Postnatal Risk Factors
por: Ding, Li, et al.
Publicado: (2020)

Variations in Umbilical Cord Hematopoietic and Mesenchymal Stem Cells With Bronchopulmonary Dysplasia
por: Chaudhury, Sonali, et al.
Publicado: (2019)

Health Care Burden of Bronchopulmonary Dysplasia Among Extremely Preterm Infants
por: Mowitz, Meredith E., et al.
Publicado: (2019)

Risk Identification of Bronchopulmonary Dysplasia in Premature Infants Based on Machine Learning
por: Lei, Jintao, et al.
Publicado: (2021)

Predictors of Developmental and Respiratory Outcomes Among Preterm Infants With Bronchopulmonary Dysplasia
por: Morag, Iris, et al.
Publicado: (2021)

Mesenchymal Stem Cell-Derived Extracellular Vesicles for the Treatment of Bronchopulmonary Dysplasia
por: Xi, Yufeng, et al.
Publicado: (2022)

The Airway Microbiome and Metabolome in Preterm Infants: Potential Biomarkers of Bronchopulmonary Dysplasia
por: Xu, Qi, et al.
Publicado: (2022)

Prediction Models for Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review
por: Peng, Hai-Bo, et al.
Publicado: (2022)

A prediction model of pulmonary hypertension in preterm infants with bronchopulmonary dysplasia
por: Wang, Chenhong, et al.
Publicado: (2022)

Role of left atrial hypertension in pulmonary hypertension associated with bronchopulmonary dysplasia
por: Sullivan, Rachel T., et al.
Publicado: (2022)

Volume-guarantee vs. pressure-limited ventilation in evolving bronchopulmonary dysplasia
por: Cuevas Guaman, Milenka, et al.
Publicado: (2022)

Optimizing ventilator support in severe bronchopulmonary dysplasia in the absence of conclusive evidence
por: Miller, Audrey N., et al.
Publicado: (2022)

Development of a novel humanized mouse model to study bronchopulmonary dysplasia
por: Birkett, Rob, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dhsbubi2787jch0hqhd64v617q